The number of multiple sclerosis (MS) cases in Japan has been steadily increasing in recent years. This study provides up-to-date information on the demographics, medical treatment and cost status of MS treatment in Japan in almost real-time by using a claims database. This article aims to assist policymakers as they reflect on treatment protocols and approaches for the efficient delivery of care for Japanese MS patients.
This article was originally published in Clinical and Experimental Neuroimmunology.
Read or print the article